TLR4 and cancer: Importantly, several key ferroptosis drivers and suppressors, including MAPK1, TLR4, ATM, ULK2, NFS1, and HMOX1, have been identified, offering potential therapeutic targets to modulate cancer cell susceptibility to ferroptosis.